Increased Cerebrospinal Fluid Production as a Possible Mechanism Underlying Caffeine's Protective Effect against Alzheimer's Disease

Alzheimer's disease (AD), the most common type of dementia among older people, is characterized by the accumulation of β-amyloid (Aβ) senile plaques and neurofibrillary tangles composed of hyperphosphorylated tau in the brain. Despite major advances in understanding the molecular etiology of th...

Full description

Bibliographic Details
Main Authors: Peter Wostyn, Debby Van Dam, Kurt Audenaert, Peter Paul De Deyn
Format: Article
Language:English
Published: Hindawi Limited 2011-01-01
Series:International Journal of Alzheimer's Disease
Online Access:http://dx.doi.org/10.4061/2011/617420
id doaj-c62fad1ecb7e463c976ab73cb3ed3093
record_format Article
spelling doaj-c62fad1ecb7e463c976ab73cb3ed30932020-11-24T20:53:40ZengHindawi LimitedInternational Journal of Alzheimer's Disease2090-02522011-01-01201110.4061/2011/617420617420Increased Cerebrospinal Fluid Production as a Possible Mechanism Underlying Caffeine's Protective Effect against Alzheimer's DiseasePeter Wostyn0Debby Van Dam1Kurt Audenaert2Peter Paul De Deyn3Department of Psychiatry, PC Sint-Amandus, Reigerlostraat 10, 8730 Beernem, BelgiumLaboratory of Neurochemistry and Behavior, Institute Born-Bunge and, Department of Biomedical Sciences, University of Antwerp, Universiteitsplein 1, 2610 Antwerp, BelgiumDepartment of Psychiatry, Ghent University Hospital, De Pintelaan 185, 9000 Ghent, BelgiumLaboratory of Neurochemistry and Behavior, Institute Born-Bunge and, Department of Biomedical Sciences, University of Antwerp, Universiteitsplein 1, 2610 Antwerp, BelgiumAlzheimer's disease (AD), the most common type of dementia among older people, is characterized by the accumulation of β-amyloid (Aβ) senile plaques and neurofibrillary tangles composed of hyperphosphorylated tau in the brain. Despite major advances in understanding the molecular etiology of the disease, progress in the clinical treatment of AD patients has been extremely limited. Therefore, new and more effective therapeutic approaches are needed. Accumulating evidence from human and animal studies suggests that the long-term consumption of caffeine, the most commonly used psychoactive drug in the world, may be protective against AD. The mechanisms underlying the suggested beneficial effect of caffeine against AD remain to be elucidated. In recent studies, several potential neuroprotective effects of caffeine have been proposed. Interestingly, a recent study in rats showed that the long-term consumption of caffeine increased cerebrospinal fluid (CSF) production, associated with the increased expression of Na+-K+ ATPase and increased cerebral blood flow. Compromised function of the choroid plexus and defective CSF production and turnover, with diminished clearance of Aβ, may be one mechanism implicated in the pathogenesis of late-onset AD. If reduced CSF turnover is a risk factor for AD, then therapeutic strategies to improve CSF flow are reasonable. In this paper, we hypothesize that long-term caffeine consumption could exert protective effects against AD at least in part by facilitating CSF production, turnover, and clearance. Further, we propose a preclinical experimental design allowing evaluation of this hypothesis.http://dx.doi.org/10.4061/2011/617420
collection DOAJ
language English
format Article
sources DOAJ
author Peter Wostyn
Debby Van Dam
Kurt Audenaert
Peter Paul De Deyn
spellingShingle Peter Wostyn
Debby Van Dam
Kurt Audenaert
Peter Paul De Deyn
Increased Cerebrospinal Fluid Production as a Possible Mechanism Underlying Caffeine's Protective Effect against Alzheimer's Disease
International Journal of Alzheimer's Disease
author_facet Peter Wostyn
Debby Van Dam
Kurt Audenaert
Peter Paul De Deyn
author_sort Peter Wostyn
title Increased Cerebrospinal Fluid Production as a Possible Mechanism Underlying Caffeine's Protective Effect against Alzheimer's Disease
title_short Increased Cerebrospinal Fluid Production as a Possible Mechanism Underlying Caffeine's Protective Effect against Alzheimer's Disease
title_full Increased Cerebrospinal Fluid Production as a Possible Mechanism Underlying Caffeine's Protective Effect against Alzheimer's Disease
title_fullStr Increased Cerebrospinal Fluid Production as a Possible Mechanism Underlying Caffeine's Protective Effect against Alzheimer's Disease
title_full_unstemmed Increased Cerebrospinal Fluid Production as a Possible Mechanism Underlying Caffeine's Protective Effect against Alzheimer's Disease
title_sort increased cerebrospinal fluid production as a possible mechanism underlying caffeine's protective effect against alzheimer's disease
publisher Hindawi Limited
series International Journal of Alzheimer's Disease
issn 2090-0252
publishDate 2011-01-01
description Alzheimer's disease (AD), the most common type of dementia among older people, is characterized by the accumulation of β-amyloid (Aβ) senile plaques and neurofibrillary tangles composed of hyperphosphorylated tau in the brain. Despite major advances in understanding the molecular etiology of the disease, progress in the clinical treatment of AD patients has been extremely limited. Therefore, new and more effective therapeutic approaches are needed. Accumulating evidence from human and animal studies suggests that the long-term consumption of caffeine, the most commonly used psychoactive drug in the world, may be protective against AD. The mechanisms underlying the suggested beneficial effect of caffeine against AD remain to be elucidated. In recent studies, several potential neuroprotective effects of caffeine have been proposed. Interestingly, a recent study in rats showed that the long-term consumption of caffeine increased cerebrospinal fluid (CSF) production, associated with the increased expression of Na+-K+ ATPase and increased cerebral blood flow. Compromised function of the choroid plexus and defective CSF production and turnover, with diminished clearance of Aβ, may be one mechanism implicated in the pathogenesis of late-onset AD. If reduced CSF turnover is a risk factor for AD, then therapeutic strategies to improve CSF flow are reasonable. In this paper, we hypothesize that long-term caffeine consumption could exert protective effects against AD at least in part by facilitating CSF production, turnover, and clearance. Further, we propose a preclinical experimental design allowing evaluation of this hypothesis.
url http://dx.doi.org/10.4061/2011/617420
work_keys_str_mv AT peterwostyn increasedcerebrospinalfluidproductionasapossiblemechanismunderlyingcaffeinesprotectiveeffectagainstalzheimersdisease
AT debbyvandam increasedcerebrospinalfluidproductionasapossiblemechanismunderlyingcaffeinesprotectiveeffectagainstalzheimersdisease
AT kurtaudenaert increasedcerebrospinalfluidproductionasapossiblemechanismunderlyingcaffeinesprotectiveeffectagainstalzheimersdisease
AT peterpauldedeyn increasedcerebrospinalfluidproductionasapossiblemechanismunderlyingcaffeinesprotectiveeffectagainstalzheimersdisease
_version_ 1716796568558895104